Withaferin A downregulates her-2/neu protein expression in human breast cancer cells.

被引:0
|
作者
Smith, Ananlise [1 ]
Poliquin, Sarah [1 ]
Lopez-Rodriguez, Darlah [1 ]
Andreansky, Samita [1 ]
机构
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
关键词
D O I
10.1158/1535-7163.TARG-13-A115
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A115
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Level of HER-2/neu protein expression in primary breast cancer may impact the development of HER-2/neu-specitic endogenous immunity.
    Goodell, V
    Waisman, J.
    Salazar, L. G.
    dela Rosa, C.
    Link, J.
    Childs, J. S.
    Higgins, D. M.
    Disis, M. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S160 - S160
  • [22] HER-2 therapy. HER-2/neu diagnostics in breast cancer
    Walter P Carney
    Kim Leitzel
    Suhail Ali
    Rainer Neumann
    Allan Lipton
    Breast Cancer Research, 9
  • [23] HER-2/neu signal transduction in human breast and ovarian cancer
    Reese, DM
    Slamon, DJ
    STEM CELLS, 1997, 15 (01) : 1 - 8
  • [24] HER-2/NEU AND FIBRINOLYTIC FACTORS IN HUMAN BREAST-CANCER
    TOMMASI, S
    RELLA, C
    GIANNELLA, C
    QUARANTA, M
    SCHITTULLI, F
    PARADISO, A
    COVIELLO, M
    DELENA, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (03) : 473 - 477
  • [25] STUDIES OF THE HER-2 NEU PROTOONCOGENE IN HUMAN BREAST-CANCER
    SLAMON, DJ
    PRESS, MF
    GODOLPHIN, W
    RAMOS, L
    HARAN, P
    SHEK, L
    STUART, SG
    ULLRICH, A
    MOLECULAR DIAGNOSTICS OF HUMAN CANCER, 1989, 7 : 371 - 384
  • [26] EGF RECEPTOR AND HER-2/NEU IN HUMAN BREAST-CANCER
    WITTLIFF, JL
    WIEHLE, RD
    MARTIN, AW
    CLINICAL CHEMISTRY, 1990, 36 (06) : 1060 - 1060
  • [27] Targeting Her-2/neu breast cancers with a plant derived natural compound, Withaferin A
    Smith, Annalise
    Marin, Susana
    Andreansky, Samita
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [28] Determining HER-2/neu expression in breast carcinoma
    Vang, R
    Abrams, J
    LABORATORY INVESTIGATION, 1999, 79 (01) : 194A - 194A
  • [29] Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer
    Mary L. Disis
    Keith L. Knutson
    Kathy Schiffman
    Kristine Rinn
    Douglas G. McNeel
    Breast Cancer Research and Treatment, 2000, 62 : 245 - 252
  • [30] Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer
    Disis, ML
    Knutson, KL
    Schiffman, K
    Rinn, K
    McNeel, DG
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 62 (03) : 245 - 252